This is a Validated Antibody Database (VAD) review about human PLXNB1, based on 9 published articles (read how Labome selects the articles), using PLXNB1 antibody in all methods. It is aimed to help Labome visitors find the most suited PLXNB1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PLXNB1 synonym: PLEXIN-B1; PLXN5; SEP

Santa Cruz Biotechnology
mouse monoclonal (A-8)
  • western blot; human; 1:500; loading ...; fig 7a
Santa Cruz Biotechnology PLXNB1 antibody (Santa Cruz, sc-28372) was used in western blot on human samples at 1:500 (fig 7a). Nat Commun (2021) ncbi
mouse monoclonal (A-8)
  • western blot; human; fig 2
Santa Cruz Biotechnology PLXNB1 antibody (Santa Cruz, sc28372) was used in western blot on human samples (fig 2). Onco Targets Ther (2016) ncbi
mouse monoclonal (A-8)
  • western blot; human; fig 3
Santa Cruz Biotechnology PLXNB1 antibody (Santa Cruz, sc-28372) was used in western blot on human samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (A-8)
  • western blot; human
Santa Cruz Biotechnology PLXNB1 antibody (Santa Cruz Biotech, A8) was used in western blot on human samples . Angiogenesis (2014) ncbi
Dako
mouse monoclonal (69.1)
  • immunohistochemistry; human; fig 1
Dako PLXNB1 antibody (DAKO, M3626) was used in immunohistochemistry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (69.1)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1a
Dako PLXNB1 antibody (Dako, 69.1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1a). Pathol Res Pract (2016) ncbi
mouse monoclonal (69.1)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 4
In order to test if atypical fibroxanthoma is the non-infiltrating precursor lesion of pleomorphic dermal sarcoma, Dako PLXNB1 antibody (Dako, M3626) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 4). Oncotarget (2016) ncbi
mouse monoclonal (69.1)
  • western blot; human; fig 3d
Dako PLXNB1 antibody (DAKO, 69.1) was used in western blot on human samples (fig 3d). Tumour Biol (2016) ncbi
mouse monoclonal (69.1)
  • western blot; human; 1:1000; loading ...; fig 1b
Dako PLXNB1 antibody (Dako, M3626) was used in western blot on human samples at 1:1000 (fig 1b). BMC Cancer (2015) ncbi
Articles Reviewed
  1. Jiang C, Javed A, Kaiser L, Nava M, Xu R, Brandt D, et al. Mechanochemical control of epidermal stem cell divisions by B-plexins. Nat Commun. 2021;12:1308 pubmed publisher
  2. Hirayama M, Tomita Y, Yuno A, Tsukamoto H, Senju S, Imamura Y, et al. An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs. Oncoimmunology. 2016;5:e1123368 pubmed publisher
  3. Ding X, Qiu L, Zhang L, Xi J, Li D, Huang X, et al. The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer. Onco Targets Ther. 2016;9:1189-204 pubmed publisher
  4. Shooshtarizadeh T, Nazeri A, Zare Mirzaie A, Movahedinia S. Expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma. Pathol Res Pract. 2016;212:335-9 pubmed publisher
  5. Helbig D, Ihle M, Pütz K, Tantcheva Poor I, Mauch C, Büttner R, et al. Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas. Oncotarget. 2016;7:21763-74 pubmed publisher
  6. Zhang X, Jung I, Hwang Y. EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression. Tumour Biol. 2016;37:2555-63 pubmed publisher
  7. Pasiliao C, Chang C, Sutherland B, Valdez S, Schaeffer D, Yapp D, et al. The involvement of insulin-like growth factor 2 binding protein 3 (IMP3) in pancreatic cancer cell migration, invasion, and adhesion. BMC Cancer. 2015;15:266 pubmed publisher
  8. Le A, Huang Y, Pingle S, Kesari S, Wang H, Yong R, et al. Plexin-B2 promotes invasive growth of malignant glioma. Oncotarget. 2015;6:7293-304 pubmed
  9. Zhou H, Yang Y, Basile J. The Semaphorin 4D-Plexin-B1-RhoA signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4. Angiogenesis. 2014;17:261-74 pubmed publisher